Last updated on March 2019

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

Brief description of study

This Phase IIIb, multicenter study will assess the safety of atezolizumab as second- to fourth-line treatment for participants with locally advanced or metastatic urothelial or non-urothelial cancer of the urinary tract in addition to evaluate the efficacy of atezolizumab and potential tumor biomarkers associated with atezolizumab.

Clinical Study Identifier: NCT02928406

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: MO29983 ...

Universit tsklinikum Erlangen; Medizinische Klinik 5; H matologie und Internistische Onkologie
Erlangen, Germany

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.